[1] ROMASZKO AM,DOBOSZYNSKA A.Multiple primary lung cancer:A literature review[J].Adv Clin Exp Med,2018,27(5):725-730.
[2] YANG S,ZHANG Z,WANG Q.Emerging therapies for small cell lung cancer[J].J Hematol Oncol,2019,12(1):47-57.
[3] TRIGO J,SUBBIAH V,BESSE B,et al.Lurbinectedin as second-line treatment for patients with small-cell lung cancer:a single-arm,open-label,phase 2 basket trial[J].Lancet Oncol,2020,21(5):645-654.
[4] WANG Y,ZOU S,ZHAO Z,et al.New insights into small-cell lung cancer development and therapy[J].Cell Biol Int,2020,44(8):1564-1576.
[5] GANJU A,KHAN S,HAFEEZ BB,et al.miRNA nanotherapeutics for cancer[J].Drug Discov Today,2017,22(2):424-432.
[6] WU M,WANG G,TIAN W,et al.MiRNA-based therapeutics for lung cancer[J].Curr Pharm Des,2018,23(39):5989-5996.
[7]JIANG W,HAN X,WANG J,et al.miR-22 enhances the radiosensitivity of small-cell lung cancer by targeting the WRNIP1[J].J Cell Biochem,2019,120(10):17650-17661.
[8] YU JG,JI CH,SHI MH.MicroRNA-26b suppresses tumorigenicity and promotes apoptosis in small cell lung cancer cells by targeting myeloid cell leukemia 1 protein[J].Kaohsiung J Med Sci,2018,34(11):593-605.
[9] CHEN H,DAI J.miR-409-3p suppresses the proliferation,invasion and migration of tongue squamous cell carcinoma via targeting RDX[J].Oncol Lett,2018,16(1):543-551.
[10] LI Y,CHEN L,ZHANG B,et al.miR-409-3p inhibits the proliferation and migration of human ovarian cancer cells by targeting Rab10[J].Cell Mol Biol,2020,66(7):197-201.
[11] CALLES A,AGUADO G,SANDOVAL C,et al.The role of immunotherapy in small cell lung cancer[J].Clin Transl Oncol,2019,21(8):961-976.
[12] MAO Y,XUE P,LI L,et al.Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-gene pairs in small-cell lung cancer[J].Mol Med Rep,2019,20(3):2199-2208.
[13] DU X,ZHANG J,WANG J,et al.Role of miRNA in lung cancer-potential biomarkers and therapies[J].Curr Pharm Des,2018,23(39):5997-6010.
[14] ZHANG G,LIU Z,XU H,et al.miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1[J].Biochem Biophys Res Commun,2016,469(2):189-195.
[15] CAO Y,ZHANG L,WEI M,et al.MicroRNA-409-3p represses glioma cell invasion and proliferation by targeting high-mobility group nucleosome-binding domain 5[J].Oncol Res,2017,25(7):1097-1107.
[16] CHEN L,HEIKKINEN L,WANG C,et al.Trends in the development of miRNA bioinformatics tools[J].Brief Bioinform,2019,20(5):1836-1852.
[17] LU TX,ROTHENBERG ME.MicroRNA[J].J Allergy Clin Immunol,2018,141(4):1202-1207.
[18] SHEN H,YIN L,DENG G,et al.Knockdown of Beclin-1 impairs epithelial-mesenchymal transition of colon cancer cells[J].J Cell Biochem,2018,119(8):7022-7031.
[19] JUNG YY,LEE YK,KOO JS.The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer[J].Expert Opin Ther Targets,2016,20(2):167-178.
[20] LEVY JMM,TOWERS CG,THORBURN A.Targeting autophagy in cancer[J].Nat Rev Cancer,2017,17(9):528-542.
[21] AMARAVADI RK,KIMMELMAN AC,DEBNATH J.Targeting autophagy in cancer:recent advances and future directions[J].Cancer Discov,2019,9(9):1167-1181.
[22] HAMURCU Z,DELIBASI N,GEENE S,et al.Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation,survival,migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/Src signaling in triple negative breast cancer cells[J].J Cancer Res Clin Oncol,2018,144(3):415-430.
[23] NAM RK,BENATAR T,AMEMIYA Y,et al.Mir-139 regulates autophagy in prostate cancer cells through Beclin-1 and mTOR signaling proteins[J].Anticancer Res,2020,40(12):6649-6663.
[24] HE JP,HOU PP,CHEN QT,et al.Flightless-I blocks p62-mediated recognition of LC3 to impede selective autophagy and promote breast cancer progression[J].Cancer Res,2018,78(17):4853-4864.